Indira Benakanakere Selected Research

Progesterone Congeners

8/2011	Apigenin prevents development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats.
9/2010	Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude mice.
9/2010	Synthetic progestins differentially promote or prevent 7,12-dimethylbenz(a)anthracene-induced mammary tumors in sprague-dawley rats.
9/2010	Apigenin blocks induction of vascular endothelial growth factor mRNA and protein in progestin-treated human breast cancer cells.
7/2006	Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Indira Benakanakere Research Topics

Disease

10	Neoplasms (Cancer) 01/2014 - 07/2006
9	Breast Neoplasms (Breast Cancer) 01/2013 - 10/2007
2	Carcinogenesis 08/2011 - 09/2010
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2014
1	Hyperplasia 08/2011
1	Ischemia 01/2011
1	Lymphatic Metastasis 09/2010
1	Breast Diseases (Breast Disease) 09/2010
1	Neoplasm Metastasis (Metastasis) 09/2010

Drug/Important Bio-Agent (IBA)

9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013 - 07/2006
8	Progestins (Progestagens)IBA 01/2013 - 07/2006
6	Estrogens (Estrogen)FDA Link 01/2013 - 10/2007
5	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 08/2011 - 01/2010
5	Progesterone CongenersIBA 08/2011 - 07/2006
4	Proteins (Proteins, Gene)FDA Link 01/2011 - 10/2007
4	Hormones (Hormone)IBA 09/2010 - 10/2007
4	Progesterone Receptors (Progesterone Receptor)IBA 09/2010 - 07/2006
3	2,2- bis(hydroxymethyl)- 1- azabicyclo(2,2,2,)octan- 3- oneIBA 01/2011 - 10/2007
3	anthraceneIBA 01/2010 - 07/2006
2	Pharmaceutical PreparationsIBA 01/2013 - 01/2011
2	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2013 - 08/2011
2	9,10-Dimethyl-1,2-benzanthraceneIBA 08/2011 - 09/2010
2	ApigeninIBA 08/2011 - 09/2010
2	Norethindrone (Norethisterone)FDA LinkGeneric 09/2010 - 09/2010
2	Norgestrel (DL-Norgestrel)FDA LinkGeneric 09/2010 - 09/2010
2	Progesterone FDA LinkGeneric 09/2010 - 07/2006
2	Mifepristone (RU 486)FDA Link 09/2010 - 07/2006
1	CholesterolIBA 01/2014
1	3- (5'- hydroxymethyl- 2'- furyl)- 1- benzylindazoleIBA 01/2013
1	Antineoplastic Agents (Antineoplastics)IBA 01/2013
1	FlavonoidsIBA 08/2011
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 08/2011
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2011
1	Monoclonal AntibodiesIBA 01/2011
1	Therapeutic UsesIBA 01/2011
1	Messenger RNA (mRNA)IBA 09/2010
1	Estradiol (Delestrogen)FDA LinkGeneric 09/2010
1	flavoneIBA 09/2010
1	Megestrol Acetate (Borea)FDA LinkGeneric 09/2010
1	Biological ProductsIBA 09/2010
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2010
1	CurcuminIBA 01/2010
1	turmeric extractIBA 01/2010
1	Estrogen ReceptorsIBA 03/2009
1	Angiogenic ProteinsIBA 03/2009
1	Cysteine (L-Cysteine)FDA Link 03/2009
1	Estrogen Receptor betaIBA 10/2007
1	Estrogen Receptor alphaIBA 10/2007
1	Angiogenesis InhibitorsIBA 07/2006
1	LigandsIBA 07/2006

Therapy/Procedure

4	Therapeutics 01/2011 - 01/2010
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2013 - 08/2011
1	Immunotherapy 01/2014
1	Aftercare (After-Treatment) 01/2011
1	Contraception (Birth Control) 09/2010
1	Injections 09/2010